Investors Research Corp’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.42M | Sell |
13,760
-6,007
| -30% | -$536K | 0.25% | 63 |
|
|
2026
Q1 | $1.42M | Sell |
19,767
-376
| -2% | -$29K | 0.27% | 59 |
|
|
2025
Q4 | $1.6M | Sell |
20,143
-394
| -2% | -$31.1K | 0.29% | 52 |
|
|
2025
Q3 | $1.55M | Hold |
20,537
| – | – | 0.29% | 58 |
|
|
2025
Q2 | $1.42M | Hold |
20,537
| – | – | 0.28% | 64 |
|
|
2025
Q1 | $1.39M | Buy |
20,537
+425
| +2% | +$25.4K | 0.3% | 61 |
|
|
2024
Q4 | $903K | Sell |
20,112
-1,595
| -7% | -$89.5K | 0.2% | 113 |
|
|
2024
Q3 | $1.36M | Buy |
21,707
+115
| +0.5% | +$6.71K | 0.3% | 65 |
|
|
2024
Q2 | $1.28M | Buy |
21,592
+875
| +4% | +$54.7K | 0.3% | 66 |
|
|
2024
Q1 | $1.65M | Buy |
20,717
+98
| +0.5% | +$7.49K | 0.39% | 50 |
|
|
2023
Q4 | $1.63M | Sell |
20,619
-731
| -3% | -$52K | 0.39% | 52 |
|
|
2023
Q3 | $1.49M | Hold |
21,350
| – | – | 0.39% | 52 |
|
|
2023
Q2 | $1.48M | Buy |
21,350
+12,945
| +154% | +$921K | 0.37% | 52 |
|
|
2023
Q1 | $625K | Sell |
8,405
-125
| -1% | -$10.5K | 0.16% | 168 |
|
|
2022
Q4 | $795K | Sell |
8,530
-75
| -0.9% | -$7.24K | 0.22% | 125 |
|
|
2022
Q3 | $821K | Hold |
8,605
| – | – | 0.25% | 110 |
|
|
2022
Q2 | $797K | Sell |
8,605
-63
| -0.7% | -$6.15K | 0.24% | 116 |
|
|
2022
Q1 | $877K | Buy |
8,668
+46
| +0.5% | +$4.83K | 0.25% | 114 |
|
|
2021
Q4 | $889K | Hold |
8,622
| – | – | 0.27% | 97 |
|
|
2021
Q3 | $732K | Buy |
8,622
+25
| +0.3% | +$2.09K | 0.25% | 121 |
|
|
2021
Q2 | $717K | Buy |
8,597
+200
| +2% | +$16.4K | 0.25% | 135 |
|
|
2021
Q1 | $632K | Sell |
8,397
-200
| -2% | -$14.6K | 0.24% | 151 |
|
|
2020
Q4 | $587K | Sell |
8,597
-50
| -0.6% | -$3.25K | 0.23% | 165 |
|
|
2020
Q3 | $505K | Sell |
8,647
-175
| -2% | -$10.9K | 0.25% | 131 |
|
|
2020
Q2 | $573K | Sell |
8,822
-50
| -0.6% | -$3.15K | 0.29% | 117 |
|
|
2020
Q1 | $526K | Sell |
8,872
-50
| -0.6% | -$3.34K | 0.33% | 100 |
|
|
2019
Q4 | $663K | Sell |
8,922
-25
| -0.3% | -$1.75K | 0.31% | 108 |
|
|
2019
Q3 | $564K | Buy |
8,947
+235
| +3% | +$13.9K | 0.29% | 121 |
|
|
2019
Q2 | $475K | Sell |
8,712
-125
| -1% | -$6.73K | 0.25% | 137 |
|
|
2019
Q1 | $477K | Buy |
8,837
+350
| +4% | +$21.6K | 0.25% | 132 |
|
|
2018
Q4 | $556K | Buy |
8,487
+502
| +6% | +$37.5K | 0.39% | 107 |
|
|
2018
Q3 | $629K | Sell |
7,985
-250
| -3% | -$17.9K | 0.36% | 112 |
|
|
2018
Q2 | $530K | Buy |
8,235
+30
| +0.4% | +$1.98K | 0.31% | 131 |
|
|
2018
Q1 | $510K | Buy |
+8,205
| New | +$589K | 0.31% | 126 |
|
Other funds holding CVS
Investors Research Corp's CVS Position: Q2 2026 in Review
Investors Research Corp reduced its CVS Health (CVS) stake by 30% in Q2 2026, selling an estimated $536K and leaving 13,760 shares worth $1.42M. The position accounts for 0.25% of the portfolio, ranked #63.
Investors Research Corp first reported a position in CVS in Q1 2018 and has held it in 34 quarters since. The position peaked at $1.65M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Investors Research Corp held 13,760 shares of CVS Health worth $1.42M as of Q2 2026.
- Investors Research Corp sold 6,007 CVS Health shares in Q2 2026, an estimated $536K.
- CVS Health made up 0.25% of Investors Research Corp's portfolio in Q2 2026, its #63 holding.
- Investors Research Corp first reported a position in CVS Health in Q1 2018 and has held it in 34 quarters since.
- Investors Research Corp's CVS Health position peaked at $1.65M in Q1 2024.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.